29 C
Vientiane
Sunday, June 8, 2025
spot_img
Home Blog Page 1004

Reds Launch Second Official Retail Store in Indonesia


SURABAYA, INDONESIA – Media OutReach Newswire – 21 January 2025 – Liverpool FC continues to strengthen its international presence in Asia with the official opening of its second retail store in Indonesia.

Reds Launch Second Official Retail Store in Indonesia

LFC legend Emile Heskey led the official opening of the club’s new official retail store in Surabaya and hosted a meet & greet with fans on Saturday 18th January. He also spent time with the Official Liverpool Supporters’ Club- BigReds -afterwards at a live screening of LFC’s Premier League fixture with Brentford.

Located in the nation’s second-most populated city within Pakuwon Mall, the new store launch follows the club’s successful debut store opening in Jakarta in July 2024 at Pondok Indah Mall 2.

The launch event included a host of activities aimed at “inspiring belief” and fostering a sense of belonging amongst LFC fans, including a visit from the club’s official mascot, Mighty Red.

Mighty Red arrived after a brief stop in Jakarta where he hosted a community event alongside the Inspiration Factory Foundation (IFF) for underprivileged children.

The new Surabaya retail store, which was identified as a key location in collaboration with the club’s official retail partner, PT Kanmo Weston Retailindo, will echo the innovative design concept of the club’s flagship store in Liverpool’s city centre at Liverpool ONE showcasing the rich architectural history of Liverpool.

Fans visiting the new store can explore the full range of replica kits, exclusive Liverpool FC fashion and accessories, as well as unique souvenirs.

Lee Dwerryhouse, senior vice president of merchandising at Liverpool FC, said: “We have over 28 million LFC followers in Indonesia, and it’s great to bring our LFC brand closer to our supporters so they can feel a part of the club. This latest store opening extends our portfolio in Asia and underscores our ambitious plans to grow our international presence in key markets.”

Manoj Bharwani, co-founder and managing director of Kanmo Group: “Following the successful opening of the first Liverpool FC Store in Jakarta last year, we have been delighted by the overwhelming enthusiasm and positive response from the club’s loyal fans in Indonesia.

“Building on this momentum, we are excited to further expand Liverpool FC’s presence in Indonesia with our new store in Pakuwon Mall, Surabaya. We are confident that this initiative will deepen the bond between the club and its passionate fanbase in the region. We would like to thank Liverpool FC Retail team for trusting Kanmo Group for this expansion.”

This Surabaya opening brings Liverpool FC’s total number of retail locations to 18 globally, with an additional store planned for 2025 in Denmark, reflecting the club’s commitment to connecting with its passionate fan base around the world.

Rajbir Chopra, sales director, Weston Corporation added: ” The past few months have been incredibly exciting for us with the successful opening of our store in Jakarta. With the opening of our second LFC store in Surabaya, we are confident that this momentum will only continue, helping us to strengthen our connection with the fans in Indonesia.

“We are committed to building a long-term relationship with LFC’s Indonesia fanbase and offering more coveted merchandise from their favourite club!”
Hashtag: #LFC

The issuer is solely responsible for the content of this announcement.

Liverpool Football Club

  • Founded in 1892, Liverpool FC is one of the world’s most historic and famous football clubs, having won 19 League Titles, including the Premier League, eight FA Cups, ten League Cups, six European Cups, three UEFA Cups, four European Super Cups, 16 Charity Shields, two Women’s Super League titles and one Women’s Championship.
  • As a socially responsible Club, Liverpool FC is proud of the work it does via the award-winning The Red Way, its ongoing commitment to creating a better future for its people, its planet and its communities. This includes efforts to improve club-wide sustainability, enhance Equality, Diversity & Inclusion in all areas, and create life changing opportunities for children and young people in Merseyside and beyond thanks to its official charity, LFC Foundation.

VINI JR. SADDLES-UP, WHILE JACK GREALISH HEADS TO JUNGLE IN LATEST PEPSI® CAMPAIGN

 THE CAMPAIGN ENCOURAGES FOOTBALL FANS TO DITCH MIDWEEK ROUTINE FOR UEFA CHAMPIONS LEAGUE ACTION

  • Campaign features two films with Pepsi ambassador Vini Jr. The first, unveiled today, features him as a cowboy transported into a traditional Telenovela scene and the second will see him taking on the role of a martial artist within the Chinese fiction genre, Wuxia
  • In a separate standalone film, we witness Jack Grealish taking on a traditional gameshow challenge in the jungle  
  • Pepsi’s latest campaign – Football Always Wins – encourages fans to break their midweek monotony, that might include watching TV game shows, Telenovela serial dramas, or Wuxia martial arts shows and to instead choose football enjoyment over everyday sameness.

LONDON, Jan. 21, 2025 /PRNewswire/ — Pepsi has launched its latest global football campaign, encouraging fans around the world to break their midweek routines to experience the enjoyment of UEFA Champions League football. Featuring ambassadors Jack Grealish and Vini Jr, the campaign sets out to show that “Football Always Wins” over other forms of entertainment.

In the set of films created for the campaign, Jack Grealish and Vini Jr. challenge fans to break with their midweek routines that might include watching TV Game Shows, Telenovela serial dramas, or Wuxia martial arts shows and to instead embrace the opportunity to watch more sport. The global campaign coincides with Pepsi partnership with the UEFA Champions League.

In the first two entertaining films, Vini Jr. is transported into the Telenovela format popular across Latin America, donning a cowboy outfit for his role. The player rides a horse towards a potential romantic partner but, just as the two lock eyes, Vini Jr. decides to choose football and instead controls a ball on his chest. The film closes with Vini Jr. standing on his horse’s saddle, demonstrating that football should always win in a choice between soap opera and a match.

Whilst this epic competition can turn a routine Tuesday or Wednesday into the best moment of the week, Pepsi’s latest campaign recognises that fans around the world encounter habits and routines which might stop them from watching and enjoying midweek games.

Vini Jr. said, “When I was younger and growing up in Brazil, I clearly remember sprinting back from school as fast as I could to catch the start of European matches. I remember being glued to the screen, dreaming of one day playing on those pitches. Now I’m there, my goals and ambitions are always about taking my game to the next level. I want to score more goals, provide more assists, and be a decisive player in every competition”.

The second film, due to be released next week, will feature Vini Jr. transported into the Chinese fiction genre, Wuxia. Two martial artists are shown preparing to fight each other but are dramatically interrupted by Vini Jr., armed only with a football. Once again, Football Always Wins. 

Vini Jr. continues, “Playing a martial artist in the new Pepsi campaign was amazing—it felt like stepping into a completely different world. But I have to say, the cowboy outfit was such an unexpected and fun look for me. As for what’s next? Who knows! Maybe I’ll get to be a superhero or even dive into the world of music”.

In a standalone film featuring Jack Grealish, we find him taking on a traditional gameshow challenge based in the jungle. The film opens with a group of contestants crawling in the mud in an attempt to find a giant ball to slot into a hole in the wall. Having struggled to complete the challenge, Jack Grealish appears from nowhere and kicks a football straight through the hole, completing the challenge and once again demonstrating that Football Always Wins.

Jack Grealish said,Those who know me know how much I love game shows. So, when Pepsi revealed I’d be taking on a series of jungle inspired challenges for its latest campaign, I couldn’t wait to get involved!”

In supporting content for the campaign Jack Grealish is dispatched to the “jungle” as he’s challenged to test himself with a series of mystery boxes to unlock the winning Pepsi and the enjoyment of mid-week football. The “Football Always Wins” campaign will later be extended with a series of social assets in which Jack and Vini Jr. encourage football fans to stop their scroll and tune-in to UEFA Champions League games. The three players will “hack” popular TikTok memes to present the match as more fulfilling entertainment.

Eric Melis, VP Global Brand Marketing at PepsiCo said: “Football has an unrivalled ability to entertain fans around the world, and nothing encapsulates this more than the UEFA Champions League. We know, however, that UEFA Champions League football alters the midweek routine and that fans around the world have weekly schedules which might keep them from experiencing the thrill of mid-week sport.

“Pepsi’s latest campaign – Football Always Wins – sets out to encourage football fans to break their midweek monotony, encouraging them to choose enjoyment over everyday sameness. Working with our incredible Global football ambassadors, Jack Grealish and Vini Jr, both of whom are known for challenging convention in the game, we’ve created a campaign which brings unrivalled entertainment to fans around the world and continues Pepsi’s philosophy to unlock pure enjoyment for those who are Thirsty For More.”

The campaign launches globally with the first of the two films released on 20 January 2025, across a range of channels. Fans can follow Pepsi channels to see more as the campaign unfolds: X (Twitter), InstagramFacebook

The Vini Jr. in Telenovela and Jack Grealish Jungle Game Show films are available here, with the final film to be released next week. 

Jack Grealish imagery is available here and Vini Jr. imagery is available here.

About PepsiCo
PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated more than $91 billion in net revenue in 2023, driven by a complimentary beverage and convenient foods portfolio that includes Lay’s, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, and SodaStream. PepsiCo’s product portfolio includes a wide range of enjoyable foods and beverages, including many iconic brands that generate more than $1 billion each in estimated annual retail sales.

Guiding PepsiCo is our vision to Be the Global Leader in Beverages and Convenient Foods by Winning with pep+ (PepsiCo Positive). pep+ is our strategic end-to-end transformation that puts sustainability and human capital at the center of how we will create value and growth by operating within planetary boundaries and inspiring positive change for planet and people. For more information, visit www.pepsico.com, and follow on X (Twitter)InstagramFacebook, and LinkedIn @PepsiCo.

 

 

Tuya to Release Smart Door Lock Solution with Matter and Home Key in Apple Wallet Support

NEW YORK, Jan. 21, 2025 /PRNewswire/ —Tuya Smart (NYSE: TUYA, HKEX: 2391), the global cloud platform service provider today introduced a new smart door lock solution that supports both the Matter protocol and home key in Apple Wallet. This allows users to seamlessly and securely add a home key to Apple Wallet to access and unlock their homes with a simple tap of an iPhone or Apple Watch.

Users can add their home key to Apple Wallet after an initial set up. The setup process is straightforward:

– First, after installing the smart door lock, the user should put the device into pairing mode.
– Next, open the Home app and scan the Matter QR code on the door lock to add it to the app.
– Once added, a “virtual home key” will instantly appear in the user’s Apple Wallet.
– Finally, users can set a PIN code within the Home App, enabling them to unlock the door using the PIN code.
– They can hold their iPhone or Apple Watch near a smart lock for convenient access.

With Express Mode, users don’t need to wake or unlock their device to use their home key—they can simply hold their device near a reader.

By leveraging Tuya’s Solution for Matter, this smart door lock seamlessly integrates with Apple Home. iPhone, iPad, and Mac users can easily manage the door lock using the Apple Home App.

Home key in Apple Wallet takes full advantage of the privacy and security features already built into iPhone and Apple Watch. Data is encrypted and protected against tampering and theft, and Apple cannot see when and where a user uses a home key in Wallet.

At CES 2025, this smart door lock solution captivated attendees, sparking widespread curiosity and drawing crowds who were eager to explore its innovative design and seamless integration of Tuya’s solutions. In addition to NFC access, the product supports multiple unlocking methods, including palm vein recognition, password entry, and app based unlocking, ensuring a smooth and versatile door-opening experience for users across various scenarios.

As an early adopter and advocate of the Matter protocol, Tuya remains steadfast in its mission to advance the global implementation of Matter-enabled smart devices. Supporting home key in Apple Wallet represents a significant milestone in Tuya’s broader strategy to align Matter product solutions with other leading ecosystems. To date, Tuya has earned over 200 Matter certifications, spanning five major categories: electrical devices, lighting, gateways, sensors, and home appliances. These certifications cover an array of smart home products, including light bulbs, LED strips, switches, gateways, sockets, sensors, curtains, and thermostats, showcasing Tuya’s comprehensive capabilities in the smart home domain.

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

  • ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing.
  • ASC30 oral tablet was generally safe and well tolerated. All adverse events (AEs) were mild (grade 1) or moderate (grade 2), and most of the AEs were gastrointestinal (GI)-related. There were no grade 3 or higher AEs as well as no serious AEs (SAEs). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and other liver enzymes were in normal ranges.
  • ASC30 oral tablet is stable at room temperature. Relative oral bioavailability of ASC30 tablet is 99% in animal models.
  • Data from the animal models utilizing a new tablet formulation of ASC30 support up to once-weekly oral dosing.
  • Topline results, including weight loss, safety and PK, from the U.S. Phase Ib multiple ascending dose (MAD) study of ASC30 oral tablet, once daily, in obese patients are expected by the end of March 2025.

HONG KONG, Jan. 21, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX:1672, “Ascletis”) announces today positive topline results from its U.S. single ascending dose (SAD) study  (NCT06680440) of ASC30 oral tablet in patients with obesity (body mass index (BMI): 30-40 kg/m2). The SAD study consists of five cohorts (2 mg, 5 mg, 10 mg, 20 mg and 40 mg) with a total of 40 patients with obesity under fasting conditions.

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the SAD study of patients with obesity, supporting once-daily or less frequent oral dosing. Cross-trial comparison indicates that in humans, drug exposure (area under the curve, “AUC”) of 5 mg ASC30 single dose is 2.2-fold of that of 6 mg orforglipron single dose [1]. ASC30 oral tablet demonstrated superior PK properties (including a longer t1/2 and higher AUC) to other small molecule oral GLP-1 receptor (GLP-1R) agonists in development [1-3], suggesting ASC30 oral tablet has the potential to be a best-in-class small molecule GLP-1R agonist to treat obesity.

In Cohort 5, 40 mg ASC30 oral tablet single dose was given orally to patients with obesity under both fasting and fed conditions. The data indicated that ASC30 oral tablet’s PK properties including AUC and t1/2 were essentially identical in the absence or presence of food, suggesting that ASC30 oral tablet can offer patient-friendly, once-daily oral dosing without food and water restrictions.

ASC30 oral tablet was generally safe and well tolerated in the Phase Ia SAD study.  All adverse events (AEs) were mild (grade 1) or moderate (grade 2), and most of the AEs were gastrointestinal (GI)-related. There were no grade 3 or higher AEs, as well as no serious AEs (SAEs). GI-related safety profiles of ASC30 oral tablet were consistent with or better than other small molecule oral GLP-1R agonists in development [1, 3, 4] (Table 1). Furthermore, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and other liver enzymes were in normal ranges.

Table 1. All GI-related AEs of ASC30 oral tablet were mild (grade 1) or moderate (grade 2)

TEAE, n (%)

Placebo
(N = 10)

Cohort 1
2 mg ASC30
(N=6)

Cohort 2
5 mg ASC30
(N=6)

Cohort 3
10 mg ASC30
(N=6)

Cohort 4
20 mg ASC30
(N=6)

Cohort 5
40 mg ASC30
(N=6)

GI-related TEAE

1 (10.0)

0

1 (16.7)

4 (66.7)

5 (83.3)

6 (100.0)

Diarrhea

0

0

1 (16.7)

0

0

0

Constipation

1 (10.0)

0

0

0

1 (16.7)

1 (16.7)

Vomiting

0

0

0

2 (33.3)

5 (83.3)

5 (83.3)

Nausea

1 (10.0)

0

1 (16.7)

3 (50.0)

5 (83.3)

6 (100.0)

TEAE: Treatment-Emergent Adverse Event; GI: Gastrointestinal; n: Number of patients who had GI-related TEAE in
each dose level; N: Number of patients who received the study drug.

ASC30 oral tablet formulation, which is stable at room temperature, was developed using Ascletis’ proprietary technology and has a relative oral bioavailability of 99% at steady state in animal models. Data from the animal models utilizing a new tablet formulation (stable at room temperature) of ASC30 support up to once-weekly oral dosing.

ASC30 was discovered and developed in-house at Ascletis as a GLP-1R biased small molecule agonist without β-arrestin recruitment.  ASC30 has unique and differentiated properties that enable the administration of one small molecule as both a once-monthly subcutaneous injection and a once-daily oral tablet. ASC30 has two- to three-fold better in vitro potency against GLP-1R when compared head-to-head with orforglipron. In the intravenous glucose tolerant test (IVGTT) in non-human primates (NHPs), ASC30 (1.5 mg/kg dose) stimulated statistically and significantly more insulin secretion when compared head-to-head with orforglipron (6 mg/kg dose).

ASC30 is the first and only small molecule GLP-1R biased agonist that can be dosed once monthly subcutaneously and once daily orally for the treatment of obesity. ASC30 oral tablet has the potential to be a best-in-class GLP-1R small molecule agonist given its PK and safety profiles as well as potency against GLP-1R.

“We are excited that the results from our Phase Ia SAD trial of ASC30 oral tablet, once daily in patients with obesity demonstrated potential best-in-class characteristics. With superior PK properties observed in the SAD study, we are looking forward to sharing efficacy, safety, and PK data from Phase Ib 28-day multiple ascending dose (MAD) trial of patients with obesity by the end of March this year,” said Dr. Jinzi Jason Wu, Founder, Chairman and CEO of Ascletis, “As one small molecule, ASC30 potentially offers both once-daily oral and once-monthly subcutaneous injection dosing options.”

ASC30 Oral Tablet U.S. Phase Ib MAD Study Update

The ASC30 oral tablet MAD study consists of 3 cohorts with weekly titrations in which patients with obesity are treated for 28 days with ASC30 oral tablet once daily or placebo. Cohort 1 (2 mg, 5 mg, 10 mg and 20 mg) has been completed. Cohort 2 (2 mg, 10 mg, 20 mg and 40 mg) and Cohort 3 (5 mg, 15 mg, 30 mg and 60 mg) are expected to be completed in late February and March 2025, respectively. Topline results from the MAD study, including weight loss, safety and PK, are expected by the end of March 2025.

ASC30 Oral Tablet U.S. Phase Ia and Ib Clinical Studies for the Treatment of Obesity

The Phase Ia study of ASC30 oral tablet once-daily is a randomized, double-blind, placebo-controlled, single ascending dose (5 cohorts) study to evaluate the safety, tolerability, and PK of ASC30 oral tablet in patients with obesity (BMI: 30-40 kg/m2).

The Phase Ib study of ASC30 oral tablet once daily is a randomized, double-blind, placebo-controlled, multiple ascending dose (3 cohorts, weekly titration, once-daily treatment for 28 days) study to evaluate the safety, tolerability, PK and efficacy of ASC30 in patients with obesity (BMI: 30-40 kg/m2).

About ASC30

ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both subcutaneous injection and oral tablet administrations. ASC30 is a new molecular entity (NME), with U.S. and global compound patent protection until 2044.

References

  1. Diabetes Obes Metab. 2023; 25:2634–2641.
  2. Obesity 2024: Volume 32, Issue S1, Poster 342.
  3. Obesity 2024: Volume 32, Issue S1, Poster 219.
  4. Diabetes 2023: Volume 72, Issue Supplement_1, Poster 754.

About Ascletis Pharma Inc.

Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on two therapeutic areas with unmet medical needs from a global perspective: metabolic diseases and viral diseases. Ascletis has multiple clinical stage drug candidates in its R&D pipeline.

For more information, please visit www.ascletis.com.

Contact:
Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com

ChipMOS ANNOUNCES NT$350 MILLION SHARE REPURCHASE PROGRAM

HSINCHU, Jan. 21, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today announced that its Board of Directors has authorized a share repurchase program with the total amount up to NT$350 million (approximately US$10.7 million, based on the exchange rate of NT$32.79 to US$1.00 as of December 31, 2024).

Under the program, the company will repurchase up to 10,000,000 shares from the open market on the Taiwan Stock Exchange, representing approximately 1.38% of its issued share capital. The shares will be repurchased within a price range of NT$21.18 to NT$35.00 per share, while the buyback will still be carried out if the stock price falls lower than the aforementioned range. The authorization repurchase program period is from January 22 to March 21, 2025.

S.J. Cheng, Chairman and President of ChipMOS, said, “Our latest repurchase authorization is inline with our capital allocation strategy and directly reflects our view that our shares are undervalued and represent a highly compelling investment opportunity. We remain confident in our financial performance, and focused on the strategic initiatives that will help drive our continued growth and leadership success, as we work to build long-term shareholder value.”

About ChipMOS TECHNOLOGIES INC.:

ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS) (www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS is known for its track record of excellence and history of innovation. The Company provides end-to-end assembly and test services to leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries serving virtually all end markets worldwide.

Forward-Looking Statements:

This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes,’ ‘expects,’ ‘anticipates,’ ‘projects,’ ‘intends,’ ‘should,’ ‘seeks,’ ‘estimates,’ ‘future’ or similar expressions or by discussion of, among other things, strategies, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, due to various factors. Further information regarding these risks, uncertainties and other factors are included in the Company’s most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s other filings with the SEC.

Contacts:

In Taiwan

Jesse Huang

ChipMOS TECHNOLOGIES INC.

+886-6-5052388 ext. 7715

IR@chipmos.com

In the U.S.

David Pasquale

Global IR Partners

+1-914-337-8801

dpasquale@globalirpartners.com

Be My Guest: The Culture Episode

GUIYANG, China, Jan. 21, 2025 /PRNewswire/ — Southwestern China’s Guizhou, often called the “Land of a Thousand Cultures,” is a province of highland and mountains. As a Chinese saying goes, in Guizhou, “Every mountain is home to an ethnic group, customs differ every ten miles, and traditions differ every hundred miles.” The province is rich in cultural diversity, showcasing its unique charm and vitality among other regions in China.


Be My Guest: The Culture Episode

The short video series”Be My Guest • Focus Guizhou“, produced by Guizhou Satellite TV and the International Communication Center of Guizhou Radio and Television Station, is a documentary about the real life of local people from the perspectives of international photographers who come to explore Guizhou.

In this episode, American photographer Dan Sandoval comes along with Chen Jing, a student in the Department of Drama and Performance at Guizhou University, to take a journey in Guizhou and experience the region’s beautiful landscape and vibrant culture.

Dan and Chen meet in Anshun city, where they delve into the 600-year-old Tunpu culture. This culture can be dated back to the Ming Dynasty when the imperial court moved part of troops and immigrants from northern China to Anshun. After the war ended, the stationed troops settled down and thereafter lived for generations. The settlers’ old customs became a legacy that is still preserved today. Through watching Anshun Dixi Opera, Dan and Chen feel the thrilling war years of the ancient settlers.

Next, they visit the Guizhou Peking Opera Theatre to watch Yangming‘s Enlightenment, a drama performance that tells the story of Wang Yangming, a renowned philosopher, educator, and military strategist in the Ming Dynasty.

Finally, they travel to Congjiang County, where they marvel at the picturesque village scenery and experience the charm of ethnic traditions. In Biasha Miao Village, they are captivated by the Miao culture of “the tree of life”, and in Gaozeng Dong village, they are enchanted by the Grand Songs of the Dong people. This ancient form of multi-part, unaccompanied choral singing has been practiced for over 2,500 years. In 2009, it was inscribed on the list of the UNESCO Intangible Cultural Heritage of Humanity.

“I’m already planning my next trip to Guizhou!” Dan says, who is deeply moved by the vibrant culture and unforgettable experience. He’s eager to return with his camera to explore more places and landscapes and immerse himself once again in the region’s culture.

https://youtu.be/3ChKzNWkGvs

Synechron Earns Great Place to Work Certification™ in 14 Countries

SYDNEY, Jan. 21, 2025 /PRNewswire/ — Synechron, Inc., a leading global digital transformation consulting firm, has been officially accredited as a Great Place to Work® Certified™ organization for 2024 to 2025 in 14 countries. This recognition is based on anonymous feedback from more than 14,500 Synechron employees collected through Great Place To Work®.

Synechron was certified in the following countries:

  • Australia
  • Bulgaria
  • Canada
  • France
  • India
  • Japan
  • Luxembourg
  • Mexico
  • Serbia
  • Singapore
  • Switzerland
  • United Arab Emirates
  • United Kingdom
  • United States of America

“With this global recognition, we reaffirm our commitment to fostering an inclusive, collaborative workplace where employees can thrive,” said Faisal Husain, Synechron’s co-founder and CEO. “Our people are at the heart of what we do, driving innovation and delivering transformative solutions for our clients.”

The Great Place To Work® Trust Index™ Survey provides valuable insights into the organization’s performance by assessing five key areas: Credibility, respect, fairness, pride, and camaraderie. These pillars reflect a positive employee experience and highlight the level of trust that employees have in the organization.

“A Great Place To Work® Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,” says Sarah Lewis-Kulin, the vice president of global recognition at Great Place To Work®. “By successfully earning this recognition, it’s evident that Synechron stands out as one of the top companies to work for, providing an excellent workplace environment for its employees.”

About Synechron:

At Synechron, we believe in the power of digital to transform businesses for the better. Our global consulting firm combines creativity and innovative technology to deliver industry-leading digital solutions. Synechron’s progressive technologies and optimization strategies span end-to-end Artificial Intelligence, Consulting, Digital, Cloud & DevOps, Data, and Software Engineering, servicing an array of noteworthy financial services and technology firms. Through research and development initiatives in our FinLabs we develop solutions for modernization, from Artificial Intelligence and Blockchain to Data Science models, Digital, cloud-native, mobile-first applications and more. Over the last 20+ years, our company has been honored with multiple employer awards, recognizing our commitment to our talented teams. With top clients to boast about, Synechron has a global workforce of 14,500+, and has 58 offices in 21 countries within key global markets. For more information on the company, please visit our website or LinkedIn community.

About Great Place To Work®

Great Place To Work® is the global authority on workplace culture. Our mission is to help every place become a great place to work for all. We give leaders and organizations the recognition and tools to create a consistently and overwhelmingly positive employee experience, fostering cultures that are proven to drive business, improve lives, and better society. Our recognition is the most coveted and respected in the world for elevating employer brands to attract the right people. Our proprietary methodology and platform enables organizations to truly capture, analyze, and understand the experience of all employees. Our groundbreaking research empowers organizations to build cultures that retain talent and unlock the potential of every employee. Our coaches, content, and community connect the boldest leaders, ideas, and innovations in employee experience. Since 1992, our Certification™, Best Workplaces™ Lists, and global benchmarks have become the industry standard, built on data from more than 100 million employees in 150 countries around the world. For more information, visit www.greatplacetowork.com.

For more information please contact:

Randall Jensen
Head of Communications & PR
Synechron
(+1) 7329438076
randall.jensen@synechron.com

Or

Rashmi Joshi
Media Relations, Synechron
(+91) 9560694654
Rashmi.Joshi@synechron.com

 

IFEZ captivates global audience with its innovative companies at CES 2025

  • IFEZ’s ‘INCHEON-IFEZ’ Booth attracts 12,000 visitors
  • Participating companies secure a foundation for global expansion, including 10 MoU signings

INCHEON, South Korea, Jan. 21, 2025 /PRNewswire/ — The Incheon Free Economic Zone Authority (IFEZ) has announced that the ‘INCHEON-IFEZ’ booth at CES 2025 showcased its vision for the future of smart cities and promoted innovative companies from Incheon to a global audience.

IFEZ captivates global audience with its innovative companies at CES 2025
IFEZ captivates global audience with its innovative companies at CES 2025

CES 2025 (Consumer Electronics Show 2025), the largest technology exhibition in the world, took place in Las Vegas, USA, from Tuesday, January 7, to Friday, January 10th.

The INCHEON-IFEZ Booth, themed “Urban Renaissance: Building Tomorrow’s Smart Cities Today,” garnered attention by demonstrating a sustainable urban future powered by advanced technologies from Incheon-based companies. During the event, the booth welcomed more than 12,000 visitors.

To boost the global presence of Incheon’s startups, IFEZ supported the participation of 41 companies at CES 2025, dividing them across various exhibition areas: 10 companies in the ‘INCHEON-IFEZ’ Booth at the Las Vegas Convention Center, 10 in the Korea pavilion (KOTRA) at the Eureka Park, 6 in the Global Pavilion, and 15 as the Incheon Startup Park Delegation.

These companies achieved record-breaking results, conducting 869 export consultations with international buyers and investors, which amounts to an estimated $400 million in potential deals.

Notably, Sheco, a company specializing in robotic solutions for recovering oil spills, was highlighted as one of the “12 Must-See Startups at CES 2025” by The Vertical, a U.S. media outlet covering tech startups, underscoring the company’s innovative capabilities.

Six companies signed 10 Memorandums of Understanding (MOUs) for tangible outcomes, creating opportunities for global market expansion and attracting investments.

Additionally, 12 companies supported by IFEZ won 13 CES Innovation Awards, setting a new record. The award-winning companies attracted significant interest from global buyers and investors, firmly establishing their innovation and technological prowess on the world stage.

At CES 2025, IFEZ actively promoted its initiatives and innovative companies through various programs. On the first day of the exhibition, the ‘Unveiled Incheon Media Stage’ was held for about 30 global media outlets. This event highlighted IFEZ’s commitments to supporting businesses with world-class infrastructure and fostering global cooperation centered on its thriving innovation ecosystem.

Also, “All Connected Incheon Night,” held on the evening of January 7 (local time), brought together distinguished global leaders, including Kate Gallego, Mayor of Phoenix; Victor Hoskins, CEO of Fairfax County Economic Development Authority; and Doug Bruhnke, CEO of Global Chamber.

IFEZ signed a Memorandum of Understanding (MoU) with Global Chamber, a global business network organization during the gathering. This collaboration aims to strengthen the partnership and better support startups in expanding worldwide.

Commissioner Yun Wonsok said, “Through this participation in CES, we have showcased IFEZ’s smart city vision to the global market and taken a step closer to our goal of becoming a ‘Global Top 10 City, Incheon.'” He emphasized, “We will continue to support IFEZ and Incheon startups in leading the global market and do our utmost to develop Incheon into a global business hub.